---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-034954"
form_type: "8-K"
ticker: "AHCO"
cik: "0001725255"
company_name: "AdaptHealth Corp."
filed_at: "2024-08-06T23:59:59+00:00"
generated_at: "2026-05-31T12:21:05.047019+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# AdaptHealth Q2 revenue $806M (+1.6% YoY); net income $19.4M; narrows guidance

## Summary
- Net revenue $806.0M vs $793.3M YoY; net income $19.4M (+39%); adjusted EBITDA $165.3M (-3.3%).
- Year-to-date operating cash flow $247.0M (+$20.4M YoY); free cash flow $77.9M (+$23.1M).
- Signed definitive agreement to divest certain non-core assets; closing expected Q3 2024.
- FY2024 guidance: net revenue $3.255-3.315B, adj. EBITDA $660-700M, free cash flow $160-180M.
- CEO Suzanne Foster noted results in line with expectations; optimistic about unified team effort.

## SEC filing metadata
- accession: 0001628280-24-034954
- form_type: 8-K
- ticker: AHCO
- cik: 0001725255
- company_name: AdaptHealth Corp.
- filed_at: 2024-08-06T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725255/000162828024034954/0001628280-24-034954-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725255/000162828024034954/ahco-20240806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-034954
- JSON: https://secwatch.observer/filing/0001628280-24-034954.json
- Plain text: https://secwatch.observer/filing/0001628280-24-034954.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.